These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25417482)

  • 1. [Attaining therapy relevant goals with ivabradin].
    Lohmann M
    MMW Fortschr Med; 2014 Oct; 156(17):71. PubMed ID: 25417482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Symptomatic coronary heart disease. Therapy with a beta blocker and ivabradine combination].
    MMW Fortschr Med; 2014 Jun; 156(11):58-9. PubMed ID: 25022105
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart rate decrease: a new paradigm in the treatment of heart failure. Insights from the SHIFT study.
    Komajda M
    Arch Cardiovasc Dis; 2011 Feb; 104(2):67-9. PubMed ID: 21402339
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symptomatic coronary heart diseases. Combination therapy is successful in general practice].
    MMW Fortschr Med; 2014 Nov; 156(20):75. PubMed ID: 25543378
    [No Abstract]   [Full Text] [Related]  

  • 5. [CHD and heart failure. Heart rate reduction guidelines as a therapy target].
    Freye R
    Med Monatsschr Pharm; 2014 Jul; 37(7):269-70. PubMed ID: 25065171
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ivabradine: heart rate reduction in coronary heart disease and chronic heart failure].
    Bruhn C
    Med Monatsschr Pharm; 2012 Jun; 35(6):202-8. PubMed ID: 22808664
    [No Abstract]   [Full Text] [Related]  

  • 7. [Coronary heart disease. Rapid heart rate has an unfavorable prognosis].
    Einecke D
    MMW Fortschr Med; 2008 Sep; 150(38):12-4. PubMed ID: 18983046
    [No Abstract]   [Full Text] [Related]  

  • 8. How many patients will benefit from a new therapy for chronic systolic heart failure, and what difference does it make?
    Borer JS
    JACC Heart Fail; 2015 Mar; 3(3):231-3. PubMed ID: 25650367
    [No Abstract]   [Full Text] [Related]  

  • 9. Ivabradine in heart failure: hope or hype?
    Deedwania PC
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):357-9. PubMed ID: 23181943
    [No Abstract]   [Full Text] [Related]  

  • 10. [Simultaneous administration of digoxin and diltiazem in patients with cardiac insufficiency and coronary heart disease].
    Pfeiffer G
    Fortschr Med; 1985 Jul; 103(26):699-702. PubMed ID: 3899880
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ivabradine -- a novel approach for heart rate lowering].
    Er F; Hoppe UC
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
    [No Abstract]   [Full Text] [Related]  

  • 12. Heart failure: ivabradine is no better than optimised beta-blocker therapy.
    Prescrire Int; 2011; 20(118):189-90. PubMed ID: 21751757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BEAUTIFUL results--the slower, the better?
    Reil JC; Böhm M
    Lancet; 2008 Sep; 372(9641):779-80. PubMed ID: 18757092
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease.
    Winniford MD; Hillis LD
    Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300
    [No Abstract]   [Full Text] [Related]  

  • 15. Heart rate as a treatable cardiovascular risk factor.
    Tardif JC
    Br Med Bull; 2009; 90():71-84. PubMed ID: 19474056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heart failure].
    Merx MW; Ertl G
    Dtsch Med Wochenschr; 2011 Apr; 136(14):700-2. PubMed ID: 21448830
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 18. Adding ivabradine may reduce elevated heart rate in acute patients when β blockers are ineffective.
    Trivi M; Forti L; Conde D; Diez M
    Am J Emerg Med; 2014 May; 32(5):471-2. PubMed ID: 24581885
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advantages and disadvantages of drug combinations in cardiovascular therapy].
    Schelling JL
    Ther Umsch; 1987 Aug; 44(8):596-600. PubMed ID: 2890217
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined treatment of coronary heart disease with diltiazem and isosorbide dinitrate].
    Beythien RD
    Dtsch Med Wochenschr; 1983 Feb; 108(5):176-80. PubMed ID: 6402353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.